Physician profile
Amit Gupta
NPI 1205982600
$2,916.49
in general payments reported to CMS, 2019-2025
22 companies · $15.33 in 2025
The $15.33 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $487 · 2021: $314 · 2022: $142 · 2023: $247 · 2024: $135 · 2025: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $867.51 | 2019-2023 | Xarelto |
| Lilly USA, LLC | $334.68 | 2019-2024 | Mounjaro, Trulicity |
| Amgen INC. | $265.10 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $254.91 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.39 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Neotract INC. | $197.07 | 2020 | |
| Glaxosmithkline, LLC. | $189.99 | 2019-2021 | |
| Medtronic, INC. | $182.50 | 2023 | Minimed 780g |
| Pfizer INC. | $72.23 | 2019-2020 | |
| Novo Nordisk INC | $68.59 | 2020-2023 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.58 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.43 | 2019-2020 | |
| Abbvie INC. | $21.15 | 2021 | |
| Redhill Biopharma INC. | $20.73 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.67 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.75 | 2019 | |
| Romark Laboratories, Lc | $11.54 | 2019 | |
| Genentech USA, INC. | $11.25 | 2019 | |
| Philips North America LLC | $10.91 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$400,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.